Postpartum GLP-1 prescriptions rise sharply among U.S. women
More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.
Read original article on The Medical News →Related news
-
COVID-19 immunity shows cross-reactivity against related bat coronaviruses
United Kingdom
-
New study reveals how VEGF-C amplifies lymphangiogenic signaling
United Kingdom
-
New strategy uncovers bioactive compounds from fragmented metagenomic data
United Kingdom
-
Faith leaders could help expand hypertension screening and education in Nigeria
United Kingdom
-
NCCN introduces first-ever evidence-based guidelines for pediatric bone sarcoma
United Kingdom
-
Ultrasensitive AMH testing offers new insights into midlife ovarian reserve
United Kingdom
-
Longer spaceflight linked to increased hip fracture rates in astronauts
United Kingdom
-
Portable paper device rapidly detects scopolamine in beverages
United Kingdom